StocksCorbus Pharmaceuticals HoldingCRBP

CRBP

Corbus Pharmaceuticals Holding

1.8600 -0.0100 (-0.53%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
1.8499
B
1.8601

Corbus Pharmaceuticals Holding

Corbus Pharmaceuticals Holdings Inc. was founded in 2009 and is based in Norwood, Massachusetts. CRBP is a Phase 3 clinical-stage pharmaceutical company, focused on therapeutics to treat rare and inflammatory and fibrotic diseases, such as: sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus... Show More
Last Month
50,741
Followers
2.82%
Investors
100% Of them have BUY positions.
An Increase of 0.34% from last trading Day

Related Markets

Allergan PLC
AGN
0 (0%)
S
192.91
B
193.32
Grifols A
GRF.MC
-0.44 (-2.21%)
S
19.48
B
19.52
Amgen Inc
AMGN
0.08 (0.04%)
S
227.41
B
227.89
Bristol-Myers Squibb Co
BMY
0.02 (0.03%)
S
60.38
B
60.49
Anthem Inc
ANTM
5.99 (1.80%)
S
339.09
B
340.35
View More
Top
Johnniv
$NSDQ100 relax. Breathe. Don’t take it personally. Don’t give up. I went in far too quick earlier but scaling in slowly now. Tech isn’t done, far from it. If you have suffered losses I did from $ZYNE (Zynerba Pharmaceuticals Inc) $CRBP (Corbus Pharmaceuticals Holding) last year and I felt like the world... Show More
Like CommentShare
null
.
Md Abu Rajib
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021 $CRBP (Corbus Pharmaceuticals Holding)
CRBP
Corbus Pharmaceuticals Holding
1.8499
-0.0100 (-0.53%)
Trade
Dragos Moruz
Edited